At a glance
- Originator Fidia Farmaceutici
- Class Antiepileptic drugs; Hydroxyquinolines; Muscle relaxants; Neuroprotectants; Small molecules
- Mechanism of Action Free radical scavengers; Glutamate receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Epilepsy
Most Recent Events
- 10 Oct 2003 Discontinued - Preclinical for Epilepsy in Italy (unspecified route)
- 14 Jan 2000 No-Development-Reported for Epilepsy in Italy (Unknown route)
- 08 Mar 1996 New profile